Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Acquired by Brandes Investment Partners LP

Brandes Investment Partners LP lifted its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 9.0% during the second quarter, Holdings Channel reports. The fund owned 165,293 shares of the company’s stock after buying an additional 13,643 shares during the quarter. Brandes Investment Partners LP’s holdings in Prestige Consumer Healthcare were worth $11,447,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. The Manufacturers Life Insurance Company lifted its position in Prestige Consumer Healthcare by 5.3% during the fourth quarter. The Manufacturers Life Insurance Company now owns 605,376 shares of the company’s stock valued at $37,061,000 after purchasing an additional 30,288 shares during the period. State Board of Administration of Florida Retirement System lifted its holdings in shares of Prestige Consumer Healthcare by 77.4% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 25,221 shares of the company’s stock valued at $1,830,000 after buying an additional 11,000 shares during the period. Congress Asset Management Co. MA boosted its stake in shares of Prestige Consumer Healthcare by 596.2% in the fourth quarter. Congress Asset Management Co. MA now owns 679,256 shares of the company’s stock worth $41,584,000 after buying an additional 581,685 shares during the last quarter. Norges Bank purchased a new position in Prestige Consumer Healthcare during the fourth quarter valued at approximately $27,739,000. Finally, BNP Paribas Financial Markets boosted its position in Prestige Consumer Healthcare by 143.4% in the 1st quarter. BNP Paribas Financial Markets now owns 51,246 shares of the company’s stock worth $3,718,000 after purchasing an additional 30,191 shares in the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on PBH. Jefferies Financial Group reiterated a “hold” rating and issued a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. DA Davidson increased their price objective on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $94.20.

Prestige Consumer Healthcare Trading Down 0.0 %

Shares of PBH opened at $71.32 on Monday. The firm’s fifty day moving average is $71.21 and its two-hundred day moving average is $69.60. The company has a quick ratio of 1.90, a current ratio of 3.23 and a debt-to-equity ratio of 0.65. The stock has a market cap of $3.53 billion, a PE ratio of 17.10, a price-to-earnings-growth ratio of 2.01 and a beta of 0.48. Prestige Consumer Healthcare Inc. has a 52-week low of $56.34 and a 52-week high of $75.80.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, August 8th. The company reported $0.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.86 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The company had revenue of $267.10 million during the quarter, compared to analysts’ expectations of $260.54 million. During the same period in the prior year, the business earned $1.06 EPS. The firm’s quarterly revenue was down 4.4% on a year-over-year basis. Research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.43 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.